Small molecule delivery through nanofibrous scaffolds for musculoskeletal regenerative engineering

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 8, 2014, Pages 1691-1699

  Carbone, Erica J ^a   Jiang, Tao ^a   Nelson, Clarke ^a   Henry, Nicole ^a   Lo, Kevin W H ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Drug delivery; Musculoskeletal disorders; Nanofibers; Small molecules; Tissue engineering

Indexed keywords

DRUG DELIVERY; MOLECULES; NANOFIBERS; REPAIR; SCAFFOLDS (BIOLOGY); TISSUE; TISSUE ENGINEERING;

ADVANCED MATERIALS; BIOACTIVE MOLECULES; CONTROLLED DELIVERY; MUSCULOSKELETAL DISORDERS; NANOFIBROUS SCAFFOLDS; SMALL MOLECULES; SMALL-MOLECULE DRUGS;

MUSCULOSKELETAL SYSTEM;

AMINE; BIOMATERIAL; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN 2; CHITOSAN; COLLAGEN; FINGOLIMOD; GELATIN; GROWTH FACTOR; HYDROXYAPATITE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MACROGOL; MICROSPHERE; MOLECULAR SCAFFOLD; NANOCOMPOSITE; OSTEOGENIC PROTEIN 1; OXYSTEROL; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; PROTEIN; PURMORPHAMINE; RESVERATROL; SIMVASTATIN; UNCLASSIFIED DRUG; ZOLEDRONIC ACID; NANOFIBER;

ADIPOSE DERIVED STEM CELL; BONE INJURY; BONE REGENERATION; CELL ADHESION; CELL DIFFERENTIATION; COLLOID; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; ELECTROSPINNING; HEMATOPOIETIC STEM CELL; HIGH THROUGHPUT SCREENING; HUMAN; MUSCULOSKELETAL DISEASE; NANOENCAPSULATION; NEURAL STEM CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; REGENERATIVE MEDICINE; REVIEW; SCANNING ELECTRON MICROSCOPY; SKULL DEFECT; SYNTHETIC BONE GRAFT; TISSUE ENGINEERING; TISSUE REGENERATION; CHEMISTRY; MUSCULOSKELETAL SYSTEM; NANOTECHNOLOGY; PROCEDURES; TISSUE SCAFFOLD; ULTRASTRUCTURE;

BIOCOMPATIBLE MATERIALS; MUSCULOSKELETAL SYSTEM; NANOFIBERS; NANOTECHNOLOGY; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84908564095     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.05.013     Document Type: Review

References (94)

1. Panel on Musculoskeletal Disorders and the Workplace, Commission on Behavioral and Social Sciences and Education, National Research Council Musculoskeletal disorders and the workplace: low back and upper extremities 2001, The National Academies Press, Washington, DC, [Available from:http://www.nap.edu/openbook.php?isbn=0309072840].
2. Aglietti P., Giron F., Buzzi R., Biddau F., Sasso F. Anterior cruciate ligament reconstruction: bone-patellar tendon-bone compared with double semitendinosus and gracilis tendon grafts. A prospective, randomized clinical trial. J Bone Joint Surg Am 2004, 86-A:2143-2155.
3. Farr J. Autologous chondrocyte implantation improves patellofemoral cartilage treatment outcomes. Clin Orthop Relat Res 2007, 463:187-194.
4. Conway J.D. Autograft and nonunions: morbidity with intramedullary bone graft versus iliac crest bone graft. Orthop Clin North Am 2010, 41:75-84. [table of contents].
5. Agarwal R., Williams K., Umscheid C.A., Welch W.C. Osteoinductive bone graft substitutes for lumbar fusion: a systematic review. J Neurosurg Spine 2009, 11:729-740.
6. Laurencin C.T., Ambrosio A.M., Borden M.D., Cooper J.A. Tissue engineering: orthopedic applications. Annu Rev Biomed Eng 1999, 1:19-46.
7. Oryan A., Alidadi S., Moshiri A., Maffulli N. Bone regenerative medicine: classic options, novel strategies, and future directions. J Orthop Surg Res 2014, 9:18.
8. Laurencin C.T., Ashe K.M., Henry N., Kan H.M., Lo K.W.-H. Delivery of small molecules for bone regenerative engineering: preclinical studies and potential clinical applications. Drug Discov Today 2014, 19:794-800.
9. Laurencin C.T., Khan Y. Regenerative engineering. Sci Transl Med 2012, 4:160.
10. Ashammakhi N., Ndreu A., Nikkola L., Wimpenny I., Yang Y. Advancing tissue engineering by using electrospun nanofibers. Regen Med 2008, 3:547-574.
11. Liu W., Thomopoulos S., Xia Y. Electrospun nanofibers for regenerative medicine. Adv Healthc Mater 2012, 1:10-25.
12. Lyu S., Huang C., Yang H., Zhang X. Electrospun fibers as a scaffolding platform for bone tissue repair. J Orthop Res 2013, 31:1382-1389.
13. Bessa P.C., Casal M., Reis R.L. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2008, 2:1-13.
14. Li Y., Fan L., Liu S., Liu W., Zhang H., Zhou T., et al. The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a. Biomaterials 2013, 34:5048-5058.
15. Taipaleenmaki H., Bjerre Hokland L., Chen L., Kauppinen S., Kassem M. Mechanisms in endocrinology: micro-RNAs: targets for enhancing osteoblast differentiation and bone formation. Eur J Endocrinol 2012, 166:359-371.
16. Masaeli E., Wieringa P.A., Morshed M., Nasr-Esfahani M.H., Sadri S., van Blitterswijk C.A., et al. Peptide functionalized polyhydroxyalkanoate nanofibrous scaffolds enhance schwann cells activity. Nanomedicine 2014, 10.1016/j.nano.2014.04.008.
17. Arslan E., Garip I.C., Gulseren G., Tekinay A.B., Guler M.O. Bioactive supramolecular peptide nanofibers for regenerative medicine. Adv Healthc Mater 2014, 10.1002/adhm.201300491.
18. Mas-Moruno C., Fraioli R., Albericio F., Manero J.M., Gil F.J. Novel peptide-based platform for the dual presentation of biologically active peptide motifs on biomaterials. ACS Appl Mater Interfaces 2014, 6:6525-6536.
19. Laize V., Tiago D.M., Aureliano M., Cancela M.L. New insights into mineralogenic effects of vanadate. Cell Mol Life Sci 2009, 66:3831-3836.
20. Leem Y.H., Lee K.S., Kim J.H., Seok H.K., Chang J.S., Lee D.H. Magnesium ions facilitate integrin alpha 2- and alpha 3-mediated proliferation and enhance alkaline phosphatase expression and activity in hBMSCs. J Tissue Eng Regen Med 2014, 10.1002/term.1861.
21. Lo K.W.-H., Ashe K.M., Kan H.M., Laurencin C.T. The role of small molecules in musculoskeletal regeneration. Regen Med 2012, 7:535-549.
22. Lo K.W.-H., Jiang T., Gagnon K.A., Nelson C., Laurencin C.T. Small molecule based musculoskeletal regenerative engineering. Trends Biotechnol 2014, 32:74-81.
23. Poppe H., Rybalkin S.D., Rehmann H., Hinds T.R., Tang X.B., Christensen A.E., et al. Cyclic nucleotide analogs as probes of signaling pathways. Nat Methods 2008, 5:277-278.
24. Wieghaus K.A., Capitosti S.M., Anderson C.R., Price R.J., Blackman B.R., Brown M.L., et al. Small molecule inducers of angiogenesis for tissue engineering. Tissue Eng 2006, 12:1903-1913.
25. Egusa H., Saeki M., Doi M., Fukuyasu S., Matsumoto T., Kamisaki Y., et al. A small-molecule approach to bone regenerative medicine in dentistry. J Oral Biosci 2010, 52:107-118.
26. Oest M.E., Dupont K.M., Kong H.J., Mooney D.J., Guldberg R.E. Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. J Orthop Res 2007, 25:941-950.
27. Bessa P.C., Casal M., Reis R.L. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2008, 2:81-96.
28. Alves H., Dechering K., Van Blitterswijk C., De Boer J. High-throughput assay for the identification of compounds regulating osteogenic differentiation of human mesenchymal stromal cells. PLoS One 2011, 6:e26678.
29. Darcy A., Meltzer M., Miller J., Lee S., Chappell S., Ver Donck K., et al. A novel library screen identifies immunosuppressors that promote osteoblast differentiation. Bone 2012, 50:1294-1303.
30. Vrijens K., Lin W., Cui J., Farmer D., Low J., Pronier E., et al. Identification of small molecule activators of BMP signaling. PLoS One 2013, 8:e59045.
31. Deng M., James R., Laurencin C.T., Kumbar S.G. Nanostructured polymeric scaffolds for orthopaedic regenerative engineering. IEEE Trans Nanobioscience 2012, 11:3-14.
32. Cook S.D., Salkeld S.L., Brinker M.R., Wolfe M.W., Rueger D.C. Use of an osteoinductive biomaterial (rhOP-1) in healing large segmental bone defects. J Orthop Trauma 1998, 12:407-412.
33. Kenawy el-R, Bowlin G.L., Mansfield K., Layman J., Simpson D.G., Sanders E.H., et al. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. J Control Release 2002, 81:57-64.
34. Liu T., Xu J., Chan B.P., Chew S.Y. Sustained release of neurotrophin-3 and chondroitinase ABC from electrospun collagen nanofiber scaffold for spinal cord injury repair. J Biomed Mater Res A 2012, 100:236-242.
35. Luu Y.K., Kim K., Hsiao B.S., Chu B., Hadjiargyrou M. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J Control Release 2003, 89:341-353.
36. Luong-Van E., Grondahl L., Chua K.N., Leong K.W., Nurcombe V., Cool S.M. Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. Biomaterials 2006, 27:2042-2050.
37. Sahoo S., Ang L.T., Goh J.C., Toh S.L. Growth factor delivery through electrospun nanofibers in scaffolds for tissue engineering applications. J Biomed Mater Res A 2010, 93:1539-1550.
38. Saraf A., Baggett L.S., Raphael R.M., Kasper F.K., Mikos A.G. Regulated non-viral gene delivery from coaxial electrospun fiber mesh scaffolds. J Control Release 2010, 143:95-103.
39. Jabbarzadeh E., Deng M., Lv Q., Jiang T., Khan Y.M., Nair L.S., et al. VEGF-incorporated biomimetic poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering. J Biomed Mater Res B Appl Biomater 2012, 100:2187-2196.
40. Alves C.M., Yang Y., Marton D., Carnes D.L., Ong J.L., Sylvia V.L., et al. Plasma surface modification of poly(D, L-lactic acid) as a tool to enhance protein adsorption and the attachment of different cell types. J Biomed Mater Res B Appl Biomater 2008, 87:59-66.
41. Liao I.C., Chen S., Liu J.B., Leong K.W. Sustained viral gene delivery through core-shell fibers. J Control Release 2009, 139:48-55.
42. Yan S., Xiaoqiang L., Shuiping L., Xiumei M., Ramakrishna S. Controlled release of dual drugs from emulsion electrospun nanofibrous mats. Colloids Surf B: Biointerfaces 2009, 73:376-381.
43. Yarin A. Coaxial electrospinning and emulsion electrospinning of core-shell fibers. Polym Adv Technol 2011, 22:310-317.
44. Ang E.S., Yang X., Chen H., Liu Q., Zheng M.H., Xu J. Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-kappaB and ERK activation. FEBS Lett 2011, 585:2755-2762.
45. Alt V., Donell S.T., Chhabra A., Bentley A., Eicher A., Schnettler R. A health economic analysis of the use of rhBMP-2 in Gustilo-Anderson grade III open tibial fractures for the UK, Germany, and France. Injury 2009, 40:1269-1275.
46. Li W., Lee M., Whang J., Siu R.K., Zhang X., Liu C., et al. Delivery of lyophilized Nell-1 in a rat spinal fusion model. Tissue Eng Part A 2010, 16:2861-2870.
47. Ionescu L.C., Lee G.C., Sennett B.J., Burdick J.A., Mauck R.L. An anisotropic nanofiber/microsphere composite with controlled release of biomolecules for fibrous tissue engineering. Biomaterials 2010, 31:4113-4120.
48. Okuda T., Tominaga K., Kidoaki S. Time-programmed dual release formulation by multilayered drug-loaded nanofiber meshes. J Control Release 2010, 143:258-264.
49. Brey D.M., Motlekar N.A., Diamond S.L., Mauck R.L., Garino J.P., Burdick J.A. High-throughput screening of a small molecule library for promoters and inhibitors of mesenchymal stem cell osteogenic differentiation. Biotechnol Bioeng 2011, 108:163-174.
50. Segar C.E., Ogle M.E., Botchwey E.A. Regulation of angiogenesis and bone regeneration with natural and synthetic small molecules. Curr Pharm Des 2013, 19:3403-3419.
51. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999, 286:1946-1949.
52. Wong E., Sangadala S., Boden S.D., Yoshioka K., Hutton W.C., Oliver C., et al. A novel low-molecular-weight compound enhances ectopic bone formation and fracture repair. J Bone Joint Surg Am 2013, 95:454-461.
53. Stadelmann V.A., Gauthier O., Terrier A., Bouler J.M., Pioletti D.P. Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study. Eur Cell Mater 2008, 16:10-16.
54. Montgomery S.R., Nargizyan T., Meliton V., Nachtergaele S., Rohatgi R., Stappenbeck F., et al. A novel osteogenic oxysterol compound for therapeutic development to promote bone growth: activation of Hedgehog signaling and osteogenesis through smoothened binding. J Bone Miner Res 2014, 10.1002/jbmr.2213.
55. Handal J.A., John T.K., Goldstein D.T., Khurana J.S., Saing M., Braitman L.E., et al. Effect of atorvastatin on the cortical bones of corticosteroid treated rabbits. J Orthop Res 2012, 30:872-876.
56. Yoshii T., Hafeman A.E., Esparza J.M., Okawa A., Gutierrez G., Guelcher S.A. Local injection of lovastatin in biodegradable polyurethane scaffolds enhances bone regeneration in a critical-sized segmental defect in rat femora. J Tissue Eng Regen Med 2012, 10.1002/term.1547.
57. Lubbeke A., Garavaglia G., Rothman K.J., Bonvin A., Roussos C., Miozzari H., et al. Statins may reduce femoral osteolysis in patients with total hip arthroplasty. J Orthop Res 2013, 31:814-820.
58. Erdman CP, Dosier CR, Olivares-Navarrete R, Baile C, Guldberg RE, Schwartz Z, et al. Effects of resveratrol on enrichment of adipose-derived stem cells and their differentiation to osteoblasts in two-and three-dimensional cultures. J Tissue Eng Regen Med 2012;6:s34-46.
59. Park J.B. The use of simvastatin in bone regeneration. Med Oral Patol Oral Cir Bucal 2009, 14:485-488.
60. Shi J., Votruba A.R., Farokhzad O.C., Langer R. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 2010, 10:3223-3230.
61. Szentivanyi A., Chakradeo T., Zernetsch H., Glasmacher B. Electrospun cellular microenvironments: understanding controlled release and scaffold structure. Adv Drug Deliv Rev 2011, 63:209-220.
62. Zhang Z., Hu J., Ma P.X. Nanofiber-based delivery of bioactive agents and stem cells to bone sites. Adv Drug Deliv Rev 2012, 64:1129-1141.
63. Shin S.H., Purevdorj O., Castano O., Planell J.A., Kim H.W. A short review: recent advances in electrospinning for bone tissue regeneration. J Tissue Eng 2012, 3. http:dx.doi.org/10.1177/2041731412443530.
64. Singh H., James E., Kan H.M., Nair L.S. Fabrication and evaluation of resveratrol loaded polymeric nanofibers. J Biomater Tissue Eng 2012, 2:228-235.
65. Kouhi M., Morsheda M., Varshosazc J., Fathi M.H. Poly (ε-caprolactone) incorporated bioactive glass nanoparticles and simvastatin nanocomposite nanofibers: preparation, characterization and in vitro drug release for bone regeneration applications. Chem Eng J 2013, 228:1057-1065.
66. Piskin E., Isoglu I.A., Bolgen N., Vargel I., Griffiths S., Cavusoglu T., et al. In vivo performance of simvastatin-loaded electrospun spiral-wound polycaprolactone scaffolds in reconstruction of cranial bone defects in the rat model. J Biomed Mater Res A 2009, 90:1137-1151.
67. Jain R. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000, 21:2475-2490.
68. Gentile P., Chiono V., Carmagnola I., Hatton P.V. An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. Int J Mol Sci 2014, 15:3640-3659.
69. Lu J.M., Wang X., Marin-Muller C., Wang H., Lin P.H., Yao Q., et al. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn 2009, 9:325-341.
70. Li W.J., Laurencin C.T., Caterson E.J., Tuan R.S., Ko F.K. Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res 2002, 60:613-621.
71. Brady M., Renzing A., Warnke P. Development of a functional nanofibrous membrane using bioactive molecules for bone tissue engineering. Regen Med 2009, 4:S77.
72. Wan D.C., Siedhoff M.T., Kwan M.D., Nacamuli R.P., Wu B.M., Longaker M.T. Refining retinoic acid stimulation for osteogenic differentiation of murine adipose-derived adult stromal cells. Tissue Eng 2007, 13:1623-1631.
73. Zhang W., Deng Z.L., Chen L., Zuo G.W., Luo Q., Shi Q., et al. Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One 2010, 5:e11917.
74. Puppi D., Piras A.M., Detta N., Dinucci D., Chiellini F. Poly(lactic-co-glycolic acid) electrospun fibrous meshes for the controlled release of retinoic acid. Acta Biomater 2010, 6:1258-1268.
75. Hughes J.E., Srinivasan S., Lynch K.R., Proia R.L., Ferdek P., Hedrick C.C. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ Res 2008, 102:950-958.
76. Petrie Aronin C.E., Sefcik L.S., Tholpady S.S., Tholpady A., Sadik K.W., Macdonald T.L., et al. FTY720 promotes local microvascular network formation and regeneration of cranial bone defects. Tissue Eng Part A 2010, 16:1801-1809.
77. Petrie Aronin C.E., Shin S.J., Naden K.B., Rios P.D., Sefcik L.S., Zawodny S.R., et al. The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720. Biomaterials 2010, 31:6417-6424.
78. Sato C., Iwasaki T., Kitano S., Tsunemi S., Sano H. Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation. Biochem Biophys Res Commun 2012, 423:200-205.
79. Das A., Segar C.E., Hughley B.B., Bowers D.T., Botchwey E.A. The promotion of mandibular defect healing by the targeting of S1P receptors and the recruitment of alternatively activated macrophages. Biomaterials 2013, 34:9853-9862.
80. Pampu A.A., Dolanmaz D., Tuz H.H., Karabacakoglu A. Experimental evaluation of the effects of zoledronic acid on regenerate bone formation and osteoporosis in mandibular distraction osteogenesis. J Oral Maxillofac Surg 2006, 64:1232-1236.
81. Seo S.W., Cho S.K., Storer S.K., Lee F.Y. Zoledronate reduces unwanted bone resorption in intercalary bone allografts. Int Orthop 2010, 34:599-603.
82. Sorensen T.C., Arnoldi J., Procter P., Beimel C., Jonsson A., Lenneras M., et al. Locally enhanced early bone formation of zoledronic acid incorporated into a bone cement plug in vivo. J Pharm Pharmacol 2013, 65:201-212.
83. Lu J., Lu J.-G., Song X.-F., Chen X.-S., Wu X.-D. Sandwich structure-like meshes fabricated via electrospinning for controllable release of zoledronic acid. Chem Res Chin Univ 2011, 27:524-527.
84. Rishton G.M. Small molecules that promote neurogenesis in vitro. Recent Pat CNS Drug Discov 2008, 3:200-208.
85. Li X.J., Hu B.Y., Jones S.A., Zhang Y.S., Lavaute T., Du Z.W., et al. Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells 2008, 26:886-893.
86. Binan L., Tendey C., De Crescenzo G., El Ayoubi R., Ajji A., Jolicoeur M. Differentiation of neuronal stem cells into motor neurons using electrospun poly-L-lactic acid/gelatin scaffold. Biomaterials 2014, 35:664-674.
87. Siddappa R., Martens A., Doorn J., Leusink A., Olivo C., Licht R., et al. cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci U S A 2008, 105:7281-7286.
88. Lo K.W.-H., Kan H.M., Ashe K.M., Laurencin C.T. The small molecule PKA-selective cyclic AMP analogue as an inducer of osteoblast-like cells differentiation and mineralization. J Tissue Eng Regen Med 2012, 6:40-48.
89. Lo K.W.-H., Kan H.M., Gagnon K.A., Laurencin C.T. One-day treatment of small molecule 8-bromo-cyclic AMP analogue induces cell-based VEGF production for in vitro angiogenesis and osteoblastic differentiation. J Tissue Eng Regen Med 2013, [Epub]. 10.1002/term.839.
90. Niu L., Zhou J., Huang Y., Chen Y., Li C. db-Cyclic adenosine monophosphate promotes axon regeneration and motor function recovery in cerebral ischemia-reperfusion rats. Neurol India 2010, 58:195-200.
91. Kim H., Zahir T., Tator C.H., Shoichet M.S. Effects of dibutyryl cyclic-AMP on survival and neuronal differentiation of neural stem/progenitor cells transplanted into spinal cord injured rats. PLoS One 2011, 6:e21744.
92. Zhu Y., Wang A., Shen W., Patel S., Zhang R., Young W., et al. Nanofibrous patches for spinal cord regeneration. Adv Funct Mater 2010, 20:1433-1440.
93. El-Amin S.F., Lu H.H., Khan Y., Burems J., Mitchell J., Tuan R.S., et al. Extracellular matrix production by human osteoblasts cultured on biodegradable polymers applicable for tissue engineering. Biomaterials 2003, 24:1213-1221.
94. Epstein N.E. Complications due to the use of BMP/INFUSE in spine surgery: the evidence continues to mount. Surg Neurol Int 2013, 4:S343-S352.